Evidence map›Paper›PMID 30549445›Full record

ArticleJournal of the International AIDS Society2018

High prevalence of binge drinking among people living with HIV in four African countries.

Marcellin N Nouaman, Michael Vinikoor, Moussa Seydi, Didier K Ekouevi, Patrick A Coffie, Lloyd Mulenga, Aristophane Tanon, Matthias Egger, François Dabis, Antoine Jaquet and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 3 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 3 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 8 countries.

Marcellin N NouamanProgramme PACCI, CHU de Treichville, Abidjan, Côte d'Ivoire.
Michael VinikoorDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Moussa SeydiService de maladies infectieuses et tropicales, CRCF, CHU de Fann, Dakar, Sénégal.
Didier K EkoueviProgramme PACCI, CHU de Treichville, Abidjan, Côte d'Ivoire.
Patrick A CoffieProgramme PACCI, CHU de Treichville, Abidjan, Côte d'Ivoire.
Lloyd MulengaUniversity Teaching Hospital, Lusaka, Zambia.
Aristophane TanonCHU de Treichville, Service de maladies infectieuses et tropicales, Abidjan, Côte d'Ivoire.
Matthias EggerInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.ORCID 0000-0001-7462-5132
François DabisINSERM U1219 Bordeaux Population Health Research, ISPED, Université de Bordeaux, Bordeaux, France.
Antoine JaquetINSERM U1219 Bordeaux Population Health Research, ISPED, Université de Bordeaux, Bordeaux, France.
Gilles WandelerService de maladies infectieuses et tropicales, CRCF, CHU de Fann, Dakar, Sénégal.ORCID 0000-0002-5278-8763
IeDEA
Université de Bordeaux · FRProgramme PAC-CI · CIUniversity of Bern · CHCentre for Infectious Disease Research in Zambia · ZMCentre Hospitalier National Universitaire de Fann · SNMinistry of Health · ZMUniversity Hospital Medical Center at Treichville · CI

Funding

Observational Antiretroviral Studies In Southern Africa (OASIS) CollaborationU01AI069924 · NIAID · UNIVERSITAT BERN · PI Cleophas Chimbetete, Mary-Ann Davies · 2006 to 2026
$55.9M
WADA (West Africa Database on Antiretroviral Therapy) CollaborationU01AI069919 · NIAID · UNIVERSITY OF BORDEAUX II · PI Didier Koumavi Ekouevi, Antoine Jaquet · 2006 to 2026
$29.9M
Impact of antiretroviral therapy on liver fibrosis in Zambian HIV/HBV patientsK01TW009998 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI VINIKOOR, MICHAEL JEFFREY · 2014 to 2017
$526k
FIC NIH HHS K01 TW009998NIAID NIH HHS U01 AI069919NIAID NIH HHS U01 AI069924
6 · The paper itself

Abstract

introductionExcessive alcohol consumption leads to unfavourable outcomes in people living with HIV (PLHIV), including reduced adherence to antiretroviral therapy (ART) and engagement into care. However, there is limited information on alcohol consumption patterns among PLHIV in sub-Saharan Africa.

methodsUsing a cross-sectional approach, the Alcohol Use Disorders Identification Test (AUDIT-C) was administered to PLHIV attending HIV clinics in Côte d'Ivoire, Togo, Senegal and Zambia (2013 to 2015). Hazardous drinking was defined as an AUDIT-C score ≥4 for men or ≥3 for women, and binge drinking as ≥6 drinks at least once per month. The prevalence of binge drinking was compared to estimates from the general population using data from the World Health Organization. Factors associated with binge drinking among persons declaring any alcohol use in the past year were assessed using a logistic regression model to estimate odds ratio (OR) and their corresponding 95% confidence intervals (CI).

resultsAmong 1824 PLHIV (median age 39 years, 62.8% female), the prevalence of hazardous alcohol use ranged from 0.9% in Senegal to 38.4% in Zambia. The prevalence of binge drinking ranged from 14.3% among drinkers in Senegal to 81.8% in Zambia, with higher estimates among PLHIV than in the general population. Male sex (OR 2.4, 95% CI 1.6 to 3.7), tobacco use (OR 1.7, 95% CI 1.0 to 2.9) and living in Zambia were associated with binge drinking.

conclusionsAlcohol consumption patterns varied widely across settings and binge drinking was more frequent in HIV-positive individuals compared to the general population. Interventions to reduce excessive alcohol use are urgently needed to optimize adherence in the era of universal ART.

Indexed as

AdultAfrica South of the SaharaBinge DrinkingCross-Sectional StudiesFemaleHIV InfectionsHumansLogistic ModelsMaleMiddle AgedPrevalencealcoholantiretroviral therapybinge drinkingHIVsub-Saharan Africaviral hepatitis

Identifiers

PMID30549445
PMCPMC6294116
OpenAlexW2904139665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.